Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""SEZARY syndrome"" wg kryterium: Temat


Starter badań:

Tytuł:
Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage.
Autorzy:
Navarro Matilla B; Departamento de Hematología, Hospital Universitario Puerta de Hierro, Madrid, España.
Ortiz Romero PL; Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
Pujol Vallverdú RM; Departamento de Dermatología, Hospital del Mar, Barcelona, España.
Combalia Escudero A; Departamento de Dermatología, Hospital Universitario Clínic i Provincial, Barcelona, España.
Zapata Paz I; Departamento de Radiación Oncológica, Hospital Universitario Puerta de Hierro, Madrid, España.
González Barca E; Departamento de Hematología, Institut Catalá d'Oncología, Hospitalet de Llobregat, Barcelona, España.
Muniesa Montserrat C; Departamento de Dermatología, Hospital Universitario de Bellvitge, Barcelona, España.
Morillo Andújar M; Departamento de Dermatología, Hospital Universitario Virgen del Rocío, Sevilla, España.
Pérez Ferriols A; Departamento de Dermatología, Hospital General Universitario de Valencia, Valencia, España.
Román Curto C; Departamento de Dermatología, Hospital General Universitario de Salamanca, Salamanca, España.
Fernández de Misa Cabrera R; Departamento de Dermatología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España.
Hospital Gil M; Departamento de Dermatología, Hospital Universitario Puerta de Hierro, Madrid, España.
Marín Niebla A; Departamento de Hematología, Hospital Universitario Vall d'Hebron/VHIO, Barcelona, España.
Rios Rull PJ; Departamento de Hematología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España.
de la Cruz Vicente F; Departamento de Hematología, Hospital Universitario Virgen del Rocío, Sevilla, España.
Izu Belloso RM; Departamento de Dermatología, Hospital de Basurto, Bilbao, España.
Martín García-Sancho A; Departamento de Hematología, Hospital General Universitario de Salamanca, Salamanca, España.
Parera Amer ME; Departamento de Dermatología, Hospital Son Llàtzer, Palma de Mallorca, España.
Córdoba Mascuñano R; Departamento de Hematología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España.
Ramón Quiles MD; Departamento de Dermatología, Hospital Clínico Universitario, Valencia, España.
Saus Carreres A; Departamento de Hematología, Hospital Clínico Universitario, Valencia, España.
Del Campo García R; Departamento de Hematología, Hospital Son Llàtzer, Palma de Mallorca, España.
Machan S; Departamento de Dermatología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España.
Viguera Ester P; Departamento Médico, Kyowa Kirin Farmacéutica, S.L., Madrid, España.
Blanco Garnelo J; Departamento Médico, Kyowa Kirin Farmacéutica, S.L., Madrid, España. Electronic address: .
Pokaż więcej
Transliterated Title:
Evaluación de los costes asociados a la enfermedad de pacientes con linfoma cutáneo de células T en España: análisis en función del estadio clínico (estudio MICADOS).
Źródło:
Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2024 Feb; Vol. 115 (2), pp. 119-129. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Skin Neoplasms*/therapy
Skin Neoplasms*/pathology
Lymphoma, T-Cell, Cutaneous*/epidemiology
Lymphoma, T-Cell, Cutaneous*/therapy
Lymphoma, T-Cell, Cutaneous*/pathology
Mycosis Fungoides*/therapy
Mycosis Fungoides*/pathology
Sezary Syndrome*/therapy
Sezary Syndrome*/pathology
Adult ; Humans ; Male ; Middle Aged ; Female ; Quality of Life ; Spain/epidemiology
Czasopismo naukowe
Tytuł:
Extracorporeal Photopheresis in Dermatological Diseases.
Autorzy:
Terhaar H; Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Saleem M; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Yusuf N; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 05; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Photopheresis*/methods
Skin Neoplasms*/pathology
Mycosis Fungoides*/pathology
Blood Component Removal*/methods
Sezary Syndrome*/therapy
Humans
Czasopismo naukowe
Tytuł:
Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review.
Autorzy:
Fernández-Guarino M; Dermatology Department, Hospital Universitario Ramón y Cajal, Instituto de Investigación Sanitaria Ramón y Cajal (Irycis), 28034 Madrid, Spain.
Ortiz P; Dermatology Department, Hospital 12 de Octubre, 28041 Madrid, Spain.
Gallardo F; Dermatology Department, Hospital del Mar, 08003 Barcelona, Spain.
Llamas-Velasco M; Dermatology Department, Hospital Universitario de la Princesa, Fundación de Investigación Biomédica de la Princesa, 28006 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 12; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphoma, T-Cell, Cutaneous*/drug therapy
Mycosis Fungoides*/pathology
Sezary Syndrome*/pathology
Leukemia-Lymphoma, Adult T-Cell*/drug therapy
Leukemia-Lymphoma, Adult T-Cell*/pathology
Skin Neoplasms*/pathology
Antibodies, Monoclonal, Humanized*
Adult ; Humans
Czasopismo naukowe
Tytuł:
Bridging the specialty gap: Update on primary cutaneous lymphomas.
Autorzy:
Olsen EA; Department of Dermatology, Duke University Medical Center, Durham, North Carolina. Electronic address: .
Hodak E; Rabin Medical Center, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel.
Geskin L; Department of Dermatology, Irving Medical Center, Columbia University, New York, New York.
Scarisbrick J; Department of Dermatology, University Hospital Birmingham, Birmingham, United Kingdom.
Pokaż więcej
Corporate Authors:
ISCL, USCLC, and EORTC-CLTG
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Feb; Vol. 90 (2), pp. 257-260. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, T-Cell, Cutaneous*/diagnosis
Lymphoma, T-Cell, Cutaneous*/therapy
Lymphoma, T-Cell, Cutaneous*/pathology
Mycosis Fungoides*/pathology
Skin Neoplasms*/diagnosis
Skin Neoplasms*/therapy
Skin Neoplasms*/pathology
Sezary Syndrome*/pathology
Humans
Czasopismo naukowe
Tytuł:
Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.
Autorzy:
Rubio-Muniz CA; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Sánchez-Velázquez A; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Arroyo-Andrés J; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Agud-de Dios M; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Tarín-Vicente EJ; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Falkenhain-López D; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Ortiz-Romero PL; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Institute i+12 CIBERONC, Medical School, University Complutense, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jan; Vol. 38 (1), pp. e102-e105. Date of Electronic Publication: 2023 Aug 31.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Sezary Syndrome*/drug therapy
Photopheresis*
Mycosis Fungoides*/drug therapy
Skin Neoplasms*/drug therapy
Humans
Raport
Tytuł:
JAAD Game Changer: "Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study".
Autorzy:
Patterson A
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jan; Vol. 90 (1), pp. 121. Date of Electronic Publication: 2023 Aug 19.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Sezary Syndrome*/diagnosis
Skin Neoplasms*/diagnosis
Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Alemtuzumab as first- and second-line treatment in patients with Sézary syndrome-The experience of a tertiary centre.
Autorzy:
Nogueira M; Department of Dermatology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.; Unit for Multidisciplinary Research in Biomedicine (UMIB), ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
Lau C; Laboratory of Cytometry, Department of Hematology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Teixeira MDA; Laboratory of Cytometry, Department of Hematology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Peixeiro R; Department of Clinical Hematology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.; Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Cabral R; Unit for Multidisciplinary Research in Biomedicine (UMIB), ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.; Department of Clinical Hematology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.; Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Fernandes I; Department of Dermatology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.; Unit for Multidisciplinary Research in Biomedicine (UMIB), ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.; Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Pokaż więcej
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jan; Vol. 38 (1), pp. e86-e88. Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:
Letter
MeSH Terms:
Alemtuzumab*/therapeutic use
Antineoplastic Agents*/therapeutic use
Sezary Syndrome*/drug therapy
Skin Neoplasms*/drug therapy
Skin Neoplasms*/chemically induced
Humans ; Antibodies, Monoclonal/therapeutic use ; Treatment Outcome
Opinia redakcyjna
Tytuł:
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome.
Autorzy:
Blanco G; Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Programme, IMIM-Hospital del Mar, Barcelona, Spain.; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
López-Aventín D; Servei de Dermatologia, Hospital del Mar, Barcelona, Spain.; Programa de Doctorat en Medicina, Departament de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Pujol RM; Servei de Dermatologia, Hospital del Mar, Barcelona, Spain.; Grup de Recerca en Malalties Inflamatòries i Neoplàsiques Dermatològiques, Inflammation and Cardiovascular Disorders Research Programme, IMIM-Hospital del Mar, Barcelona, Spain.
Gómez-Llonín A; Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Programme, IMIM-Hospital del Mar, Barcelona, Spain.; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Laboratori de Recerca Translacional en Microambient Tumoral, Cancer Research Programme, Barcelona, Spain.
Puiggros A; Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Programme, IMIM-Hospital del Mar, Barcelona, Spain.; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
López-Sánchez M; Servicio de Inmunología, Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, Murcia, Spain.
Estrach T; Servei de Dermatologia, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
García-Muret MP; Servei de Dermatologia, Hospital de Sant Pau, Barcelona, Spain.
López-Lerma I; Servei de Dermatologia, Hospital Vall d'Hebron, Barcelona, Spain.
Servitje O; Servei de Dermatologia, Hospital de Bellvitge, Barcelona, Spain.
Bellosillo B; Grup de Recerca Clínica Aplicada en Neoplàsies Hematològiques, Cancer Research Programme, IMIM-Hospital del Mar, Barcelona, Spain.; Laboratori de Biologia Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
Muro M; Servicio de Inmunología, Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, Murcia, Spain.
Espinet B; Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Programme, IMIM-Hospital del Mar, Barcelona, Spain.; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
Rabionet R; Departament de Genètica, Microbiologia i Estadística, Universitat de Barcelona, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.; Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Gallardo F; Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Programme, IMIM-Hospital del Mar, Barcelona, Spain.; Servei de Dermatologia, Hospital del Mar, Barcelona, Spain.
Pokaż więcej
Źródło:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2023 Dec; Vol. 37 (23-24), pp. e24982. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Sezary Syndrome*/genetics
Sezary Syndrome*/pathology
Skin Neoplasms*/genetics
Psoriasis*
Humans ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Receptors, Antigen, T-Cell/genetics ; Complementarity Determining Regions/genetics ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe
Tytuł:
Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
Autorzy:
Gao J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Ren S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Choonoo G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Chen G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Frleta D; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Zhong J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Gupta N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Sharma P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Oyejide A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Atwal GS; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Macdonald L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Murphy A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Kuhnert F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Pokaż więcej
Źródło:
Disease models & mechanisms [Dis Model Mech] 2023 Oct 01; Vol. 16 (10). Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Skin Neoplasms*/metabolism
Lymphoma, T-Cell, Cutaneous*/pathology
Sezary Syndrome*/metabolism
Sezary Syndrome*/pathology
Humans ; Animals ; Mice ; Interleukin-15 ; Lymphocytes/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Autorzy:
Latzka J; Department of Dermatology and Venereology, University Hospital of St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria; Karl Landsteiner Institute of Dermatological Research, Department of Dermatology and Venereology, University Hospital of St. Pölten, St. Pölten, Austria. Electronic address: .
Assaf C; Department of Dermatology, HELIOS Klinikum Krefeld, Krefeld, Germany; Institute for Molecular Medicine, Medical School Hamburg, University of Applied Sciences and Medical University, Hamburg, Germany; Department of Dermatology, HELIOS Klinikum Schwerin, University Campus of The Medical School Hamburg, Schwerin, Germany.
Bagot M; Department of Dermatology, Hopital Saint Louis, Université Paris Cité, INSERM U976, Paris, France.
Cozzio A; Department of Dermatology and Allergology, Kantonspital St. Gallen, St. Gallen, Switzerland.
Dummer R; Department of Dermatology, University of Zurich, Zurich, Switzerland.
Guenova E; Department of Dermatology, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Gniadecki R; Department of Dermatology, University of Copenhagen, Copenhagen, Denmark; Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Hodak E; Cutaneous Lymphoma Unit, Davidoff Cancer Center, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Jonak C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Klemke CD; Hautklinik, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Knobler R; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Morrris S; Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK.
Nicolay JP; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Mannheim, Germany.
Ortiz-Romero PL; Department of Dermatology, Hospital Universitario 12 de Octubre, Institute i+12, CIBERONC, Medical School, University Complutense, Madrid, Spain.
Papadavid E; National and Kapodistrian University of Athens, 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece.
Pimpinelli N; Department of Health Sciences, Division of Dermatology, University of Florence, Florence, Italy.
Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Ranki A; Department of Dermatology and Allergology, Inflammation Center, Helsinki University Central Hospital, Helsinki, Finland.
Scarisbrick J; Department of Dermatology, University Hospital Birmingham, Birmingham, UK.
Stadler R; University Department of Dermatology, Venereology, Allergology and Phlebology, Skin Cancer Center, Johannes Wesling Medical Centre Minden, Ruhr University Bochum, Bochum, Germany.
Väkevä L; Department of Dermatology and Allergology, Inflammation Center, Helsinki University Central Hospital, Helsinki, Finland.
Vermeer MH; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Wehkamp U; Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Medical Department, Medical School of Hamburg, Hamburg, Germany.
Whittaker S; St. John's Institute of Dermatology, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Willemze R; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Trautinger F; Department of Dermatology and Venereology, University Hospital of St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria; Karl Landsteiner Institute of Dermatological Research, Department of Dermatology and Venereology, University Hospital of St. Pölten, St. Pölten, Austria.
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113343. Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mycosis Fungoides*/pathology
Sezary Syndrome*/therapy
Sezary Syndrome*/pathology
Lymphoma, T-Cell, Cutaneous*/drug therapy
Skin Neoplasms*/drug therapy
Skin Neoplasms*/pathology
Humans ; Consensus ; Quality of Life ; Immunologic Factors/therapeutic use
Czasopismo naukowe
Tytuł:
Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series.
Autorzy:
Tang H; Department of Pathology, Yale School of Medicine, New Haven, CT.
Matsumoto N; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Foss F; Department of Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT.
Xu M; Department of Pathology, Yale School of Medicine, New Haven, CT.
Ahmed A; Department of Pathology, Rush University Medical Center, Chicago, IL. Electronic address: aadil_.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Nov; Vol. 23 (11), pp. e405-e410. Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Journal Article
MeSH Terms:
Skin Neoplasms*/pathology
Mycosis Fungoides*/pathology
Sezary Syndrome*/pathology
Lymphoma, Large-Cell, Anaplastic*
Lymphoma, T-Cell, Cutaneous*/pathology
Humans ; Skin/pathology ; Bone Marrow/pathology
Czasopismo naukowe
Tytuł:
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments.
Autorzy:
Stuver R; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Geller S; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Oct 05; Vol. 14, pp. 1284045. Date of Electronic Publication: 2023 Oct 05 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
Sezary Syndrome*/drug therapy
Skin Neoplasms*/drug therapy
Skin Neoplasms*/diagnosis
Mycosis Fungoides*/drug therapy
Mycosis Fungoides*/pathology
Lymphoma, T-Cell, Cutaneous*/pathology
Mycoses*
Humans ; Quality of Life
Czasopismo naukowe
Tytuł:
Journal Club: Mycosis fungoides and Sézary syndrome: an update on a classic disease.
Autorzy:
González DV; Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Rosell-Díaz ÁM; Department of Dermatology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
Chircop I; Department of Dermatology, Hôpital Edouard Herriot, Lyon, France, CIRI, Centre International de Recherche en Infectiologie, (Team Epidermal Immunity and Allergy); INSERM, U1111; Univ Lyon; Université de Lyon 1; École Normale Supérieure de Lyon; CNRS, UMR 5308, Lyon, France.
Lé AM; Department of Dermatology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Dege T; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
Byrne N; Department of Dermatology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.
Reynaud V; CIRI, Centre International de Recherche en Infectiologie, (Team Epidermal Immunity and Allergy); INSERM, U1111; Univ Lyon; Université de Lyon 1; École Normale Supérieure de Lyon; CNRS, UMR 5308, Lyon, France, Department of Allergology and Immunology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
García-Piqueras P; Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Pokaż więcej
Źródło:
European journal of dermatology : EJD [Eur J Dermatol] 2023 Dec 01; Vol. 33 (6), pp. 714-718.
Typ publikacji:
Journal Article
MeSH Terms:
Sezary Syndrome*/complications
Mycosis Fungoides*/complications
Skin Neoplasms*/complications
Humans
Czasopismo naukowe
Tytuł:
PD-1 Overexpression in Sézary Syndrome Is Epigenetically Regulated.
Autorzy:
Najidh S; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .
Zoutman WH; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Schrader AMR; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Willemze R; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Tensen CP; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Vermeer MH; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Pokaż więcej
Źródło:
The Journal of investigative dermatology [J Invest Dermatol] 2023 Dec; Vol. 143 (12), pp. 2538-2541.e7. Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:
Journal Article
MeSH Terms:
Sezary Syndrome*/genetics
Skin Neoplasms*/genetics
Humans ; Programmed Cell Death 1 Receptor/genetics
Czasopismo naukowe
Tytuł:
Unraveling the Mechanisms of PD-1 Regulation in Sézary Syndrome: Epigenetic Regulation as Potential Mechanism?
Autorzy:
Querfeld C; Department of Pathology, City of Hope, Duarte, California, USA; Division of Dermatology, Department of Surgery, City of Hope, Duarte, California, USA; Beckman Research Institute, City of Hope, Duarte, California, USA. Electronic address: .
Pokaż więcej
Źródło:
The Journal of investigative dermatology [J Invest Dermatol] 2023 Dec; Vol. 143 (12), pp. 2338-2339. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Sezary Syndrome*/genetics
Skin Neoplasms*/genetics
Humans ; Epigenesis, Genetic ; Programmed Cell Death 1 Receptor/genetics
Czasopismo naukowe
Tytuł:
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.
Autorzy:
Hu M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Hindenburgdamm 27, 12203, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Scheffel J; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Hindenburgdamm 27, 12203, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Elieh-Ali-Komi D; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Hindenburgdamm 27, 12203, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Maurer M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Hindenburgdamm 27, 12203, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Hawro T; Department of Dermatology, Allergology and Venereology, Institute and Comprehensive Center for Inflammation Medicine, University Medical Center Schleswig-Holstein, Lübeck, Germany. .
Metz M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Hindenburgdamm 27, 12203, Berlin, Germany. .; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany. .
Pokaż więcej
Źródło:
Clinical and experimental medicine [Clin Exp Med] 2023 Dec; Vol. 23 (8), pp. 4177-4197. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphoma, T-Cell, Cutaneous*/complications
Lymphoma, T-Cell, Cutaneous*/drug therapy
Skin Neoplasms*/complications
Skin Neoplasms*/drug therapy
Mycosis Fungoides*/pathology
Sezary Syndrome*/pathology
Humans ; Quality of Life ; Pruritus/drug therapy
Czasopismo naukowe
Tytuł:
Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas.
Autorzy:
Sonego B; Dermatology Clinic, University of Trieste, 35125 Trieste, Italy.
Ibatici A; UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Rivoli G; UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Angelucci E; UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Sola S; Surgical Pathology, Galliera Hospital, 16128 Genoa, Italy.
Massone C; Dermatology Unit & Scientific Directorate, Galliera Hospital, 16128 Genoa, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Nov 20; Vol. 12 (22). Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Skin Neoplasms*/pathology
Mycosis Fungoides*/pathology
Sezary Syndrome*/pathology
Antineoplastic Agents*/therapeutic use
Humans ; Brentuximab Vedotin/therapeutic use ; Antibodies, Monoclonal/therapeutic use
Czasopismo naukowe
Tytuł:
Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors.
Autorzy:
Quadri I; The Ohio State University College of Medicine, Columbus, OH, United States.
Reneau JC; Division of Hematology, The Ohio State University Wexner Medical Center and The James and Solove Research Center and Cancer Hospital, Columbus, OH, United States.
Hanel W; Division of Hematology, The Ohio State University Wexner Medical Center and The James and Solove Research Center and Cancer Hospital, Columbus, OH, United States.
Chung CG; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Nov 03; Vol. 14, pp. 1291259. Date of Electronic Publication: 2023 Nov 03 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Sezary Syndrome*/drug therapy
Janus Kinase Inhibitors*
Skin Neoplasms*/drug therapy
Mycosis Fungoides*/drug therapy
Lymphoma, T-Cell, Cutaneous*
Humans ; Antibodies, Monoclonal/therapeutic use ; Immunotherapy
Czasopismo naukowe
Tytuł:
Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data.
Autorzy:
Assaf C; Department of Dermatology and Venerology, HELIOS Klinikum Krefeld, Krefeld, Germany.; Institute for Molecular Medicine, Hamburg Medical School, Hamburg, Germany.; Department of Dermatology, HELIOS Klinikum Schwerin, University Campus of the Hamburg Medical School, Schwerin, Germany.
Dobos G; Clinic for Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Joint Faculty of Medicine of Freie Universität Berlin and Humboldt-Universität Berlin, Berlin, Germany.
Zech IM; Kyowa Kirin GmbH, Düsseldorf, Germany.
Doess A; Kyowa Kirin GmbH, Düsseldorf, Germany.
May M; Kyowa Kirin GmbH, Düsseldorf, Germany.
Jadasz J; Kyowa Kirin GmbH, Düsseldorf, Germany.
Pokaż więcej
Źródło:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2023 Nov; Vol. 21 (11), pp. 1320-1327. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, T-Cell, Cutaneous*/epidemiology
Lymphoma, T-Cell, Cutaneous*/pathology
Skin Neoplasms*/epidemiology
Skin Neoplasms*/pathology
Mycosis Fungoides*/pathology
Sezary Syndrome*
Humans ; Male ; Aged ; Female ; Cross-Sectional Studies ; Retrospective Studies ; Germany/epidemiology
Czasopismo naukowe
Tytuł:
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care.
Autorzy:
Hawkins N; Visible Analytics, Oxford, OX2 0DP, UK.
Muszbek N; Visible Analytics, Oxford, OX2 0DP, UK.
Evans R; Visible Analytics, Oxford, OX2 0DP, UK.
McNamara L; Kyowa Kirin, Payor Value and Patient Access, Marlow, SL7 1HZ, UK.
Jones T; Kyowa Kirin, Payor Value and Patient Access, Marlow, SL7 1HZ, UK.
Pokaż więcej
Źródło:
Journal of comparative effectiveness research [J Comp Eff Res] 2023 Oct; Vol. 12 (10), pp. e230017. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sezary Syndrome*/drug therapy
Skin Neoplasms*/drug therapy
Mycosis Fungoides*/drug therapy
Lymphoma, T-Cell, Cutaneous*/drug therapy
Humans ; Standard of Care ; United Kingdom/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies